Filing Details
- Accession Number:
- 0001140361-16-047513
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-11 17:50:06
- Reporting Period:
- 2015-02-09
- Filing Date:
- 2016-01-11
- Accepted Time:
- 2016-01-11 17:50:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1509261 | Antriabio Inc. | ANTB | Pharmaceutical Preparations (2834) | 273440894 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1314773 | C Nevan Elam | 1450 Infinite Drive Louisville CO 80027 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-09 | 842,949 | $0.00 | 0 | No | 4 | S | Indirect | Konus Advisory Group, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Konus Advisory Group, Inc. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Warrant to Purchase Common Stock | Disposition | 2015-02-09 | 39,117 | $0.00 | 39,117 | $1.25 |
Common Shares | Series A Convertible Preferred Stock | Acquisiton | 2015-12-10 | 76,923 | $1.95 | 76,923 | $1.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-03-31 | 2019-03-31 | No | 4 | S | Indirect |
76,923 | 2015-12-10 | No | 4 | P | Direct |
Footnotes
- Reported securities were held by Konus Advisory Group, Inc., of which reporting person is significant holder, managing member & director. On Feb. 9, 2015, as part of extinguishment of $1,441,795 Konus debt, reported securities were transferred in entirety (giving effect to 1 for 8 reverse split). Reporting person no longer maintains voting or dispositive power of Issuer's shares & warrants previously held by Konus.
- The Series A Preferred Stock is convertible into common stock of Issuer at price per share of $1.95, subject to terms and conditions of Private Placement Memorandum dated November 3, 2015.
- The Series A Preferred Stock has no expiration date.